APG Asset Management US Inc. Sells 3,791 Shares of HCA Healthcare, Inc. (NYSE:HCA)

APG Asset Management US Inc. decreased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 48.7% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 4,000 shares of the company’s stock after selling 3,791 shares during the period. APG Asset Management US Inc.’s holdings in HCA Healthcare were worth $1,201,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Congress Wealth Management LLC DE increased its position in shares of HCA Healthcare by 3.4% during the fourth quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company’s stock valued at $312,000 after acquiring an additional 34 shares in the last quarter. Evergreen Private Wealth LLC grew its holdings in shares of HCA Healthcare by 0.3% in the fourth quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company’s stock worth $3,838,000 after acquiring an additional 35 shares during the period. Mediolanum International Funds Ltd lifted its stake in shares of HCA Healthcare by 0.3% in the 4th quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company’s stock worth $3,153,000 after purchasing an additional 36 shares during the period. Prairie Wealth Advisors Inc. increased its holdings in HCA Healthcare by 6.1% in the 4th quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company’s stock valued at $210,000 after acquiring an additional 40 shares during the last quarter. Finally, Whittier Trust Co. grew its holdings in shares of HCA Healthcare by 3.6% in the fourth quarter. Whittier Trust Co. now owns 1,195 shares of the company’s stock valued at $359,000 after purchasing an additional 41 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

HCA has been the topic of several recent analyst reports. Morgan Stanley reduced their price target on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. KeyCorp dropped their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. Barclays lowered their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research report on Monday, January 27th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a report on Tuesday, December 17th. Finally, Truist Financial decreased their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $385.67.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares in the company, valued at $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.30% of the stock is owned by corporate insiders.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $331.05 on Wednesday. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The stock has a fifty day moving average price of $327.29 and a two-hundred day moving average price of $337.96. The firm has a market cap of $81.51 billion, a P/E ratio of 15.07, a PEG ratio of 1.10 and a beta of 1.48.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter last year, the business earned $5.90 EPS. Research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were issued a dividend of $0.72 per share. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend was Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.87%. HCA Healthcare’s dividend payout ratio is currently 13.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.